The authors argue that the extreme pediatric crowding seen during the 2022 health crisis has become a routine condition in emergency care by 2026.
Tue 4:30 AMStat News
Medicine and Healthcare
Topic overview
Medical advances, patient care, health systems, and policy decisions shaping health outcomes and the delivery of care.
Yesterday’s Recap
Monday, October 26, 2026
Cancer advances lead a day of healthcare consolidation and policy shifts
Oncology supplied the day's clearest clinical momentum, with survival data in endometrial cancer, strong KRAS results in lung cancer, a late-stage ovarian result, and an AI signal for earlier pancreatic cancer detection. Moderna's vaccine program generated both broader ambitions and a higher bar from investors, making validation and execution as important as the platform's promise.
Outside cancer, Bon Secours's $5.7 billion Surgery Partners acquisition showed outpatient consolidation continuing at scale. At the same time, looser health record software rules shifted more security and accountability onto hospitals.
25 stories from 10 sources
Dive DeeperLatest Stories
Recently curated for this topic.
The authors argue that emerging cancer vaccines will reach patients slowly unless the health system addresses major barriers before demand arrives.
Tue 4:30 AMStat News
A community in Pennsylvania Dutch country is creating its own drug company after waiting for established biopharma firms to address a problem it considers urgent.
Tue 4:30 AMStat News
Sandoz’s chief executive is calling for policies that would help European producers compete with cheaper Chinese antibiotics. The company operates one of Europe’s last penicillin plants and warns that its loss would create medical supply and sovereignty risks.
Tue 2:00 AMFortune
Sanofi’s new chief faces pressure to develop fresh blockbuster medicines that can eventually offset the company’s reliance on Dupixent sales.
Tue 1:00 AMFinancial Times
Roche presented strong clinical data for divarasib, its KRAS-targeted drug for lung cancer, at this year's ESMO meeting. The results stand out among the conference's lung cancer studies.
Mon 7:17 PMStat News
The Trump administration removed several security, privacy and transparency requirements for vendors of electronic health record software used by hospitals. The changes reduce compliance obligations for companies that build and maintain systems handling sensitive patient data.
Mon 5:16 PMStat NewsModerna CEO Stephane Bancel said the personalized mRNA cancer vaccine being developed with Merck could work across multiple tumor types, not just melanoma. He also said a recent data leak did not originate with either company.
Mon 3:59 PMBloomberg Markets
A reduction in available Medicare Advantage plans in 2027 could leave some seniors facing higher out-of-pocket health costs. Some may turn to home equity, including reverse mortgages, to help cover those expenses.
Mon 2:47 PMHousing Wire
The Pope underwent surgery to remove a tumour from the lower part of his right lung and is gradually returning to his duties. His planned South American trip will proceed as scheduled.
Mon 2:46 PMBBC
Earthquake survivors in Venezuela who underwent amputations are adapting to major physical and psychological changes. Experts say recovery will likely require lifelong rehabilitation and support.
Mon 1:55 PMAl Jazeera
A House lawmaker is investigating whether the three largest pharmacy benefit managers used audits to retaliate against independent pharmacies. The inquiry focuses on whether those audits were punitive rather than legitimate efforts to detect improper billing.
Mon 12:26 PMStat News
GSK's oncology business, rebuilt after the company exited cancer a decade ago, is approaching a potential sixth cancer-drug approval. The development signals continued progress in its return to the field.
Mon 12:20 PMStat News
A Phase 3 trial found that an antibody-drug conjugate developed by Merck and Kelun-Biotech reduced the risk of death by one-third in patients with advanced endometrial cancer. The result supports the drug's potential as a treatment for this difficult-to-treat disease.
Mon 11:30 AMStat News
Uganda is requiring citizens returning from the Democratic Republic of Congo to undergo a 21-day quarantine. It is also barring most travelers who have been in the country from transiting through Uganda.
Mon 10:27 AMBBC
Incyte reported that its targeted pancreatic cancer drug, used with chemotherapy, produced lasting tumor responses in certain patients. The findings were presented at the European Society for Medical Oncology meeting.
Mon 9:57 AMStat News
Investor enthusiasm for Moderna's experimental cancer treatment has weakened after expectations for its Phase 3 data became exceptionally high. The shift reflects growing scrutiny of whether the treatment can meet the market's elevated hopes.
Mon 9:50 AMMarketWatchAn affiliate of Bon Secours Mercy Health will acquire Surgery Partners for an enterprise value of $5.7 billion. The transaction gives the nonprofit hospital system a larger foothold in outpatient surgical care.
Mon 9:14 AMBloomberg MarketsOct 27, 2026Stat News
Opinion: Emergency pediatric care is now in permanent crisis mode
Summary
The authors argue that the extreme pediatric crowding seen during the 2022 health crisis has become a routine condition in emergency care by 2026.
The shift from episodic surge to chronic overload means hospitals cannot solve the problem with
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
A permanent pediatric emergency backlog turns a capacity problem into a structural threat to safety and access.
Oct 27, 2026Stat News
Opinion: Cancer vaccines are finally here. How do we get them to patients?
Summary
The authors argue that emerging cancer vaccines will reach patients slowly unless the health system addresses major barriers before demand arrives.
The central challenge is no longer only scientific development but delivery: testing, manufacturing, clinical integration,
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
A breakthrough treatment has limited public value if health systems cannot identify eligible patients and deliver it at scale.
Oct 27, 2026Stat News
STAT+: Pennsylvania Dutch country, tired of waiting for biopharma, builds drug company of its own
Summary
A community in Pennsylvania Dutch country is creating its own drug company after waiting for established biopharma firms to address a problem it considers urgent.
The project shifts responsibility for drug development from distant commercial firms to a local institution
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The experiment could offer a model for communities that cannot rely on mainstream biopharma to serve small or neglected patient populations.
Oct 27, 2026Fortune
‘Why do we value a Mars bar more than life-saving medicine?’ Sandoz CEO calls for level playing field with cheap Chinese antibiotics
Summary
Sandoz’s chief executive is calling for policies that would help European producers compete with cheaper Chinese antibiotics. The company operates one of Europe’s last penicillin plants and warns that its loss would create medical supply and sovereignty risks.
Low prices are putting pressure on the economics of antibiotic production even as governments depend
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The fight over antibiotic pricing is also a fight over whether Europe retains the capacity to produce critical medicines.
Oct 27, 2026Financial Times
Sanofi’s new CEO hunts for next blockbuster
Summary
Sanofi’s new chief faces pressure to develop fresh blockbuster medicines that can eventually offset the company’s reliance on Dupixent sales.
Sanofi must turn its pipeline into major commercial products before Dupixent’s growth slows. The CEO’s
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Sanofi’s future growth and valuation increasingly depend on whether it can replace a single major engine of sales.
Oct 26, 2026Stat News
STAT+: Roche gets a lung cancer win with its KRAS drug divarasib
Summary
Roche presented strong clinical data for divarasib, its KRAS-targeted drug for lung cancer, at this year's ESMO meeting. The results stand out among the conference's lung cancer studies.
The data strengthen Roche's position in the race to develop effective treatments for KRAS-driven lung
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
A credible KRAS treatment could expand options for a molecularly defined group of lung cancer patients with limited therapies.
Oct 26, 2026Stat News
STAT+: HHS relaxes security, transparency rules for health record software used by hospitals
Summary
The Trump administration removed several security, privacy and transparency requirements for vendors of electronic health record software used by hospitals. The changes reduce compliance obligations for companies that build and maintain systems handling sensitive patient data.
The policy shifts more responsibility for cybersecurity and accountability from vendors to hospitals and other
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Weaker baseline requirements could widen security differences across hospitals and increase exposure of patient data.
Oct 26, 2026Bloomberg Markets
Moderna CEO Sees Cancer Vaccines Working Beyond Melanoma
Summary
Moderna CEO Stephane Bancel said the personalized mRNA cancer vaccine being developed with Merck could work across multiple tumor types, not just melanoma. He also said a recent data leak did not originate with either company.
The key shift is an expansion of the vaccine's potential commercial and clinical scope beyond
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
A successful platform could reshape cancer treatment, but the claim remains ahead of the evidence.
Oct 26, 2026Housing Wire
Could a pullback in Medicare Advantage plans boost reverse mortgages?
Summary
A reduction in available Medicare Advantage plans in 2027 could leave some seniors facing higher out-of-pocket health costs. Some may turn to home equity, including reverse mortgages, to help cover those expenses.
The potential pullback would shift more financial pressure onto older adults, particularly those with limited
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Higher Medicare costs could push more seniors toward borrowing against their homes to remain financially stable.
Oct 26, 2026BBC
Pope's South American trip to go ahead as planned after lung cancer surgery
Summary
The Pope underwent surgery to remove a tumour from the lower part of his right lung and is gradually returning to his duties. His planned South American trip will proceed as scheduled.
The decision to keep the trip on the calendar signals that doctors and Vatican officials
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The trip will test whether the Pope can resume international duties without compromising his recovery.
Oct 26, 2026Al Jazeera
How Venezuela’s earthquake amputees adapt to life without limbs
Summary
Earthquake survivors in Venezuela who underwent amputations are adapting to major physical and psychological changes. Experts say recovery will likely require lifelong rehabilitation and support.
The lasting challenge is not the initial surgery but the absence of sustained rehabilitation, prosthetics,
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The survivors' outcomes will be shaped by years of rehabilitation and support, not only by disaster response.
Oct 26, 2026Stat News
STAT+: House lawmaker probes PBMs for ‘punitive’ audits of independent pharmacies
Summary
A House lawmaker is investigating whether the three largest pharmacy benefit managers used audits to retaliate against independent pharmacies. The inquiry focuses on whether those audits were punitive rather than legitimate efforts to detect improper billing.
The investigation raises fresh pressure on PBMs, which already face scrutiny over their control of
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Congress is testing whether PBM oversight tools are being used to discipline pharmacies that challenge their terms.
Oct 26, 2026Stat News
STAT+: GSK sees its return to cancer start to pay off
Summary
GSK's oncology business, rebuilt after the company exited cancer a decade ago, is approaching a potential sixth cancer-drug approval. The development signals continued progress in its return to the field.
A sixth approval would give GSK a broader oncology portfolio and reduce its dependence on
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
GSK is turning a once-abandoned therapeutic area into a meaningful source of future growth.
Oct 26, 2026Stat News
STAT+: Merck ADC drug cut risk of death by one-third in advanced endometrial cancer
Summary
A Phase 3 trial found that an antibody-drug conjugate developed by Merck and Kelun-Biotech reduced the risk of death by one-third in patients with advanced endometrial cancer. The result supports the drug's potential as a treatment for this difficult-to-treat disease.
The mortality benefit strengthens the case for the drug to move toward regulatory review and
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
A survival benefit in Phase 3 could change treatment options for patients with advanced endometrial cancer.
Oct 26, 2026BBC
Nurse killed in attack while responding to Ebola alert in DR Congo
Summary
Uganda is requiring citizens returning from the Democratic Republic of Congo to undergo a 21-day quarantine. It is also barring most travelers who have been in the country from transiting through Uganda.
Uganda is tightening border controls to contain the risk of imported disease from the Democratic
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The policy shows how quickly a cross-border health threat can become a regional mobility and logistics problem.
Oct 26, 2026Stat News
STAT+: Incyte pancreatic cancer medicine induces lasting tumor responses, company says at ESMO
Summary
Incyte reported that its targeted pancreatic cancer drug, used with chemotherapy, produced lasting tumor responses in certain patients. The findings were presented at the European Society for Medical Oncology meeting.
The key shift is evidence that the combination may deliver durable benefit for a defined
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
A durable response in a treatment-resistant cancer could support a new targeted approach, but the evidence must still show broad and clinically meaningful benefit.
Oct 26, 2026MarketWatch
The excitement around Moderna’s cancer vaccine is cooling. Here’s why.
Summary
Investor enthusiasm for Moderna's experimental cancer treatment has weakened after expectations for its Phase 3 data became exceptionally high. The shift reflects growing scrutiny of whether the treatment can meet the market's elevated hopes.
The decisive issue is the gap between a promising cancer program and the unusually strong
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Moderna's cancer ambitions now face a higher evidentiary and financial bar than a typical clinical readout.
Oct 26, 2026Bloomberg Markets
Bain-Backed Surgery Partners Purchased in $5.7 Billion Deal
Summary
An affiliate of Bon Secours Mercy Health will acquire Surgery Partners for an enterprise value of $5.7 billion. The transaction gives the nonprofit hospital system a larger foothold in outpatient surgical care.
The deal shifts more outpatient surgery capacity into a nonprofit hospital system with the scale
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The acquisition accelerates consolidation in outpatient surgery and expands a major hospital system's influence beyond its own facilities.
3 stories · 3 sources
Last Week’s Recap
Oct 19 - 25, 2026
Ebola outbreak expands across borders
Oct 20 - Oct 25across 6 daysImpact
Ebola outbreak crosses borders
Ebola expanded across Nigeria, Kenya, Uganda, and other linked settings as Kenya recorded household transmission and authorities widened quarantine and contact tracing. A vaccine trial in Congo added a longer-term effort to strengthen outbreak preparedness.
8 threads
Dive DeeperRecent days
Walk back in time.
Mon, Oct 26Cancer advances lead a day of healthcare consolidation and policy shifts25 storiesSun, Oct 25Evidence reshapes everyday prevention and treatment13 storiesSat, Oct 24Kenya’s Ebola cluster leads a day of provisional cancer advances12 storiesFri, Oct 23Cancer vaccine advances, while Ebola tests outbreak control33 storiesThu, Oct 22Promising medical advances collide with investor and access realities30 storiesWed, Oct 21Ebola’s Cross-Border Spread Sets the Day’s Health Agenda27 storiesTue, Oct 20Outbreaks Expand as Healthcare Systems Face Strain26 storiesMon, Oct 19Women’s health gets a new federal structure, but impact awaits funding18 storiesSun, Oct 18Outbreaks and war put healthcare under pressure12 storiesSat, Oct 17Ebola outbreak expands while Pope begins recovery after cancer surgery14 storiesFri, Oct 16Public-health strain deepens from war, outbreaks, and emergency-care delays16 storiesThu, Oct 15Health systems faced pressure from outbreaks and policy shifts25 storiesWed, Oct 14Outbreaks and institutional strain expose healthcare’s weak points28 storiesTue, Oct 13Cancer diagnosis puts Pope Leo's papacy on a new timeline28 stories
Make it yours
Build Your First Pass.
Pick your topics, set your cadence, and receive your personalized First Pass in your inbox. It’s that simple!